Author profile

Guillem Pratx

Department of Radiation Oncology, Stanford University

Presenting AuthorPaper
Computation Dosimetry of Radioligand Therapy Using Spatial Transcriptomics

Numerous radioligand therapy (RLT) agents are under various stages of development for treating late-stage cancers. We developed a computational methodology for identifying promising targets for RLT based on spatial transcriptomics analysis of tumor tissue.

Proffered Program · Radiopharmaceuticals, Theranostics, and Nuclear Medicine